Patient groups and the pharmaceutical industry will on February 29 tune into Finance Minister Arun Jaitley to see if the Centre holds up the promise of increasing healthcare spends from about 1 per cent of GDP to about 2.5 per cent. While rural health programmes are likely to get their share, it is all quiet on plans to roll out urban health missions. The pharmaceutical and medical-technology sectors will be looking for sops to support increased local manufacture and research. But what the aam aadmi will be looking for is how the government will make medicines and health services more affordable and accessible. Will it be through sops for private health insurance or government-supported universal health insurance programmes?